Biosimilar drug developer Coherus jumps into IPO pool By: San Francisco Business Times via Business Journals September 25, 2014 at 16:42 PM EDT Biosimilar drug developer Coherus BioSciences Inc. wants to raise $86.25 million in an initial public offering... Read More >> Related Stocks: Eli Lilly